Literature DB >> 18249138

Homology modeling of breast cancer resistance protein (ABCG2).

Eszter Hazai1, Zsolt Bikádi.   

Abstract

BCRP (also known as ABCG2, MXR, and ABC-P) is a member of the ABC family that transports a wide variety of substrates. BCRP is known to play a key role as a xenobiotic transporter. Since discovering its role in multidrug resistance, considerable efforts have been made in order to gain deeper understanding of BCRP structure and function. The recent study was aimed at predicting BCRP structure by creating a homology model. Based on sequence similarity with known structures of full-length, NB and TM domain of ABC transporters, TM, NB, and linker regions of BCRP were defined. The NB domain of BCRP was modeled using MalK as a template. Based on secondary structure prediction of BCRP and comparison of the transmembrane connecting regions of known structures of ABC transporters, the TM domain arrangement of BCRP was established and was found to resemble to that of the recently published crystal structure of Sav1866. Thus, an initial alignment of TM domain of BCRP was established using Sav1866 as a template. This alignment was subsequently refined using constrains derived from secondary structure and TM predictions and the final model was built. Finally, the complete homodimer ABCG2 model was generated using Sav1866 as template. Furthermore, known ligands of BCRP were docked to our model in order to define possible binding sites. The results of molecular dockings of known BCRP substrates to the BCRP model were in agreement with recently published experimental data indicating multiple binding sites in BCRP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18249138     DOI: 10.1016/j.jsb.2007.12.001

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  35 in total

1.  3D structural models of transmembrane proteins.

Authors:  Alexandre G de Brevern
Journal:  Methods Mol Biol       Date:  2010

2.  Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo.

Authors:  Kamlesh Sodani; Atish Patel; Nagaraju Anreddy; Satyakam Singh; Dong-Hua Yang; Rishil J Kathawala; Priyank Kumar; Tanaji T Talele; Zhe-Sheng Chen
Journal:  Biochem Pharmacol       Date:  2014-02-22       Impact factor: 5.858

Review 3.  Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Zhanglin Ni; Zsolt Bikadi; Mark F Rosenberg; Qingcheng Mao
Journal:  Curr Drug Metab       Date:  2010-09       Impact factor: 3.731

4.  The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantrone.

Authors:  Mark F Rosenberg; Zsolt Bikadi; Janice Chan; Xiaoping Liu; Zhanglin Ni; Xiaokun Cai; Robert C Ford; Qingcheng Mao
Journal:  Structure       Date:  2010-03-14       Impact factor: 5.006

5.  Expression and function of human MRP1 (ABCC1) is dependent on amino acids in cytoplasmic loop 5 and its interface with nucleotide binding domain 2.

Authors:  Surtaj H Iram; Susan P C Cole
Journal:  J Biol Chem       Date:  2010-12-20       Impact factor: 5.157

6.  ARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2.

Authors:  De-Shen Wang; Atish Patel; Hong-May Sim; Yun-Kai Zhang; Yi-Jun Wang; Rishil J Kathawala; Hui Zhang; Tanaji T Talele; Suresh V Ambudkar; Rui-Hua Xu; Zhe-Sheng Chen
Journal:  J Cell Biochem       Date:  2014-08       Impact factor: 4.429

7.  Substrate-dependent breast cancer resistance protein (Bcrp1/Abcg2)-mediated interactions: consideration of multiple binding sites in in vitro assay design.

Authors:  Nagdeep Giri; Sagar Agarwal; Naveed Shaik; Guoyu Pan; Ying Chen; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2008-12-04       Impact factor: 3.922

Review 8.  PharmGKB summary: very important pharmacogene information for ABCG2.

Authors:  Alison E Fohner; Deanna J Brackman; Kathleen M Giacomini; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2017-11       Impact factor: 2.089

9.  ABC transporters and isothiocyanates: potential for pharmacokinetic diet-drug interactions.

Authors:  Urvi Telang; Yan Ji; Marilyn E Morris
Journal:  Biopharm Drug Dispos       Date:  2009-10       Impact factor: 1.627

10.  2,3-Dihydro-1-benzofuran derivatives as a series of potent selective cannabinoid receptor 2 agonists: design, synthesis, and binding mode prediction through ligand-steered modeling.

Authors:  Philippe Diaz; Sharangdhar S Phatak; Jijun Xu; Frank R Fronczek; Fanny Astruc-Diaz; Charles M Thompson; Claudio N Cavasotto; Mohamed Naguib
Journal:  ChemMedChem       Date:  2009-10       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.